Skip to content

Oral appliance for sleep disordered breathing and in patients with heart failure

Randomized controlled trial of an oral appliance (SomnoDent) for sleep disordered breathing and cardiac function in patients with heart failure

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032210655
Enrollment
32
Registered
2022-03-09
Start date
2022-05-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disordered breathing (SDB), heart failure (HF) Apnea hypopnea index (AHI), Brain natrium peptide (BNP), Left ventricular ejection fraction (LVEF)

Interventions

Sponsors

Kasai Takatoshi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Male or female >=20 years old 2) NYHA functional class >=II 3) Either HFrEF (LVEF =100 pg/mL or serum NT-proBNP level >=400 pg/mL) 4) Coexisting SDB (AHI of >=10 and percentage of central AHI per total AHI of <=70%) 5) Ability of attaching/detaching oral appliance 6) the use of beta blocker for more than 3 months and no change in medication within 2 weeks 7) the follow-up PSG is scheduled in registration 8) Craniofacial X-ray (cephalogram) and CT are scheduled in registration

Exclusion criteria

Exclusion criteria: 1) Insufficient teeth for splint retention 2) Evidence of active periodontal disease or dental caries 3) Change in HF drugs in 2 weeks 4)ACS (including STEMI, non-STEMI, and unstable angina) 5)Cardiac surgery (open heart surgery) within 3 months 6)Severe valvular heart disease 7) Life-threatening malignancy 8) COPD with oxygen inhalation 9) End-stage renal disease 10) Pregnancy 11) Occupational driver

Design outcomes

Primary

MeasureTime frame
Apnea-hypopnea index (AHI)

Secondary

MeasureTime frame
Brain natrium peptide (BNP), Left ventricular ejection fraction (LVEF), Urinary catecholamine excretion, 6 minute walk test, Health related quality of life (SF-8, MLHFQ)

Contacts

Public ContactTakatoshi Kasai

Juntendo University Hospital

tkasai@juntendo.ac.jp+81-3-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026